RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ADMA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for ADMA Biologics Inc stock after gaining 2.66%
(Updated on Feb 26, 2024)


Buy or Hold candidate since Nov 28, 2023 Gain 45.16% PDF
The ADMA Biologics Inc stock price gained 2.66% on the last trading day (Monday, 26th Feb 2024), rising from $5.26 to $5.40. During the last trading day the stock fluctuated 4.32% from a day low at $5.21 to a day high of $5.44. The price has risen in 6 of the last 10 days and is up by 3.05% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 665 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $10.27 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 49.57% during the next 3 months and, with a 90% probability hold a price between $7.89 and $8.59 at the end of this 3-month period.

ADMA Signals & Forecast

The ADMA Biologics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.28 and $5.15. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, February 12, 2024, and so far it has fallen -1.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for ADMA Biologics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.07 and $4.81. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ADMA Biologics Inc finds support just below today's level at $5.07. If this is broken, then the next support from accumulated volume will be at $4.81 and $4.52.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.225 between high and low, or 4.32%. For the last week the stock has had daily average volatility of 3.51%.

Our recommended stop-loss: $5.18 (-4.10%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (ADMA) For The Upcoming Trading Day Of Tuesday 27th

For the upcoming trading day on Tuesday, 27th we expect ADMA Biologics Inc to open at $5.35, and during the day (based on 14 day Average True Range), to move between $5.23 and $5.57, which gives a possible trading interval of +/-$0.175 (+/-3.23%) up or down from last closing price. If ADMA Biologics Inc takes out the full calculated possible swing range there will be an estimated 6.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.46 (1.11%) than the support at $5.07 (6.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ADMA Biologics Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ADMA Biologics Inc stock to perform well in the short-term.

Current score: 3.773 Open Broker Account

Buy Candidate Unchanged

Predicted Opening Price for ADMA Biologics Inc of Tuesday, February 27, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price February 27, 2024 Current price
$5.35 ( 0.96%) $5.40

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.57 3.21 %
R2 5.49 1.62 %
R1 5.43 0.635 %
Current price: 5.40
Support S1 5.26 -2.55 %
S2 5.21 -3.53 %
S3 5.12 -5.12 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 5.46 1.11 %
Current price 5.40
Support S1 5.07 -6.11%
S2 4.81 -10.93%
S3 4.52 -16.30%
What is the symbol for ADMA Biologics Inc Stock and on which exchange is it traded?
The symbol for ADMA Biologics Inc is ADMA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ADMA Biologics Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ADMA Biologics Inc stock to perform well in the short-term.

How to buy ADMA Biologics Inc Stock?
ADMA Biologics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ADMA Biologics Inc Stock.

What's the current price of ADMA Biologics Inc Stock?
As of the end of day on the 2024-02-26, the price of an ADMA Biologics Inc (ADMA) share was $5.40.

What is the 52-week high and low for ADMA Biologics Inc Stock?
The 52-week high for ADMA Biologics Inc Stock is $5.46 and the 52-week low is $2.95.

What is the market capitalization of ADMA Biologics Inc Stock?
As of the 2024-02-26, the market capitalization of ADMA Biologics Inc is 1.189B.

When is the next earnings date for ADMA Biologics Inc?
The upcoming earnings date for ADMA Biologics Inc is Mar 28, 2024.

Click to get the best stock tips daily for free!

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ... ADMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT